In vivo experiments confirmed the pivotal role of the TREM2-DAP12-SYK pathway in obesity development, highlighting the efficacy of SMRR and EGCG in mitigating obesity through this pathway. The gene discussed is TREM2; the disease is obesity due to melanocortin 4 receptor deficiency.